Attenuation of oxidative stress and cardiac dysfunction by bisoprolol in an animal model of dilated cardiomyopathy
- 1 November 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 350 (1) , 105-113
- https://doi.org/10.1016/j.bbrc.2006.09.026
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Relationship between tumor necrosis factor-alpha production and oxidative stress in the failing hearts of patients with dilated cardiomyopathyJournal of the American College of Cardiology, 2001
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000
- Bradycardia and the Role of β-Blockade in the Amelioration of Left Ventricular DysfunctionCirculation, 2000
- Mitochondrial Electron Transport Complex I Is a Potential Source of Oxygen Free Radicals in the Failing MyocardiumCirculation Research, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The role of oxidative stress in the genesis of heart diseaseCardiovascular Research, 1998
- Double-Blind, Placebo-Controlled Study of the Long-term Efficacy of Carvedilol in Patients With Severe Chronic Heart FailureCirculation, 1995
- Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.Circulation, 1994
- Beneficial effects of metoprolol in idiopathic dilated cardiomyopathyThe Lancet, 1993
- Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathyJournal of the American College of Cardiology, 1993